Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) announced financial results for its fiscal 2017 first quarter ended December 31, 2016. Selected Fiscal 2017 First Quarter and …
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) announced financial results for its fiscal 2016 fourth quarter and year ended September 30, 2016. The company is hosting …
Valeant Pharmaceuticals Intl Inc Valeant Pharmaceuticals Intl Inc (NYSE:VRX) saw its shares falling nearly 10% today, after Dow Jones reported that talks to sell …
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) are currently plummeting 62% in pre-market trading after yesterday’s announcement that the biotech firm has discontinued all of its …
Shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) tumbled nearly 60% in after-hours trading, after the RNAi therapeutics company said that it will discontinue development of clinical stage …
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) delivered a poster presentation with Phase 1 clinical data and an oral presentation with preclinical data on ARC-AAT, its …
Chardan is divided when it comes to forecasts moving forward for biotech stocks Novavax, Inc. (NASDAQ:NVAX) and Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR).
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) investors are having a rough day following the news that deaths observed in non-human primate toxicology studies put the company’s ARC-520 program, …
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) and Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH) announced an agreement to perform collaborative studies on Arrowhead’s ARC-520 and Spring Bank’s …
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) shares are up nearly 6% as of this writing, after the RNAi therapeutics company announced a collaboration with Amgen (NASDAQ:AMGN) …
